BackMirum Pharmaceuticals Overview

Mirum Pharmaceuticals Current Cash

Mirum Pharmaceuticals's current cash is $330M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$330.73M
44.98% YoYΔ $102.61M vs prior year quarter

Peer trimmed avg / median

Loading

Mirum Pharmaceuticals Current Cash History

Loading

Mirum Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Mirum Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Mirum Pharmaceuticals (MIRM) FAQ

As of the most recent data (June 2026), MIRM shows a current cash of $330M. That compares with $230M in the prior-year period — up 45.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MIRM's current cash is now $330M (was $230M) — a 45.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Mirum Pharmaceuticals is outperforming or lagging.

Tracking MIRM's current cash over time shows whether Mirum Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $330M That compares with $230M in the prior-year period — up 45.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Mirum Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $330M) with ownership activity and broader fundamentals.

Mirum Pharmaceuticals's current cash is $330M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.